TY - JOUR
T1 - Chorioamnionitis and Risk for Maternal and Neonatal Sepsis
T2 - A Systematic Review and Meta-analysis
AU - Beck, Celeste
AU - Gallagher, Kelly
AU - Taylor, Leigh A.
AU - Goldstein, Jeffery A.
AU - Mithal, Leena B.
AU - Gernand, Alison D.
N1 - Funding Information:
Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) Award Number TL1TR002016 and by the NIH National Institute of Allergy and Infectious Diseases Award Number K23 AI139337.
Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - OBJECTIVE:To estimate the risk of maternal and neonatal sepsis associated with chorioamnionitis.DATA SOURCES:PubMed, BIOSIS, and ClinicalTrials.gov databases were systematically searched for full-text articles in English from inception until May 11, 2020.METHODS OF STUDY SELECTION:We screened 1,251 studies. Randomized controlled trials, case-control, or cohort studies quantifying a relationship between chorioamnionitis and sepsis in mothers (postpartum) or neonates born at greater than 22 weeks of gestation were eligible. Studies were grouped for meta-analyses according to exposures of histologic or clinical chorioamnionitis and outcomes of maternal or neonatal sepsis.TABULATION, INTEGRATION, AND RESULTS:One hundred three studies were included, and 55 met criteria for meta-analysis (39 studies of preterm neonates, 10 studies of general populations of preterm and term neonates, and six studies of late preterm and term neonates). Study details and quantitative data were abstracted. Random-effects models were used to generate pooled odds ratios (ORs); most studies only reported unadjusted results. Histologic chorioamnionitis was associated with confirmed and any early-onset neonatal sepsis (unadjusted pooled ORs 4.42 [95% CI 2.68-7.29] and 5.88 [95% CI 3.68-9.41], respectively). Clinical chorioamnionitis was also associated with confirmed and any early-onset neonatal sepsis (unadjusted pooled ORs 6.82 [95% CI 4.93-9.45] and 3.90 [95% CI 2.74-5.55], respectively). Additionally, histologic and clinical chorioamnionitis were each associated with higher odds of late-onset sepsis in preterm neonates. Confirmed sepsis incidence was 7% (early-onset) and 22% (late-onset) for histologic and 6% (early-onset) and 26% (late-onset) for clinical chorioamnionitis-exposed neonates. Three studies evaluated chorioamnionitis and maternal sepsis and were inconclusive.CONCLUSION:Both histologic and clinical chorioamnionitis were associated with early- and late-onset sepsis in neonates. Overall, our findings support current guidelines for preventative neonatal care. There was insufficient evidence to determine the association between chorioamnionitis and maternal sepsis.SYSTEMATIC REVIEW REGISTRATION:PROSPERO, CRD42020156812.
AB - OBJECTIVE:To estimate the risk of maternal and neonatal sepsis associated with chorioamnionitis.DATA SOURCES:PubMed, BIOSIS, and ClinicalTrials.gov databases were systematically searched for full-text articles in English from inception until May 11, 2020.METHODS OF STUDY SELECTION:We screened 1,251 studies. Randomized controlled trials, case-control, or cohort studies quantifying a relationship between chorioamnionitis and sepsis in mothers (postpartum) or neonates born at greater than 22 weeks of gestation were eligible. Studies were grouped for meta-analyses according to exposures of histologic or clinical chorioamnionitis and outcomes of maternal or neonatal sepsis.TABULATION, INTEGRATION, AND RESULTS:One hundred three studies were included, and 55 met criteria for meta-analysis (39 studies of preterm neonates, 10 studies of general populations of preterm and term neonates, and six studies of late preterm and term neonates). Study details and quantitative data were abstracted. Random-effects models were used to generate pooled odds ratios (ORs); most studies only reported unadjusted results. Histologic chorioamnionitis was associated with confirmed and any early-onset neonatal sepsis (unadjusted pooled ORs 4.42 [95% CI 2.68-7.29] and 5.88 [95% CI 3.68-9.41], respectively). Clinical chorioamnionitis was also associated with confirmed and any early-onset neonatal sepsis (unadjusted pooled ORs 6.82 [95% CI 4.93-9.45] and 3.90 [95% CI 2.74-5.55], respectively). Additionally, histologic and clinical chorioamnionitis were each associated with higher odds of late-onset sepsis in preterm neonates. Confirmed sepsis incidence was 7% (early-onset) and 22% (late-onset) for histologic and 6% (early-onset) and 26% (late-onset) for clinical chorioamnionitis-exposed neonates. Three studies evaluated chorioamnionitis and maternal sepsis and were inconclusive.CONCLUSION:Both histologic and clinical chorioamnionitis were associated with early- and late-onset sepsis in neonates. Overall, our findings support current guidelines for preventative neonatal care. There was insufficient evidence to determine the association between chorioamnionitis and maternal sepsis.SYSTEMATIC REVIEW REGISTRATION:PROSPERO, CRD42020156812.
UR - http://www.scopus.com/inward/record.url?scp=85107085790&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107085790&partnerID=8YFLogxK
U2 - 10.1097/AOG.0000000000004377
DO - 10.1097/AOG.0000000000004377
M3 - Review article
C2 - 33957655
AN - SCOPUS:85107085790
SN - 0029-7844
VL - 137
SP - 1007
EP - 1022
JO - Obstetrics and gynecology
JF - Obstetrics and gynecology
IS - 6
ER -